Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vaishnavi Mahalingam"'
Autor:
Rebekah M. Dedrick, Bailey E. Smith, Rebecca A. Garlena, Daniel A. Russell, Haley G. Aull, Vaishnavi Mahalingam, Ashley M. Divens, Carlos A. Guerrero-Bustamante, Kira M. Zack, Lawrence Abad, Christian H. Gauthier, Deborah Jacobs-Sera, Graham F. Hatfull
Publikováno v:
mBio, Vol 12, Iss 2 (2021)
Mycobacterium abscessusM. abscessus
Externí odkaz:
https://doaj.org/article/a1429c89df084465ad5faebbbb90a391
Autor:
Rebekah M. Dedrick, Haley G. Aull, Deborah Jacobs-Sera, Rebecca A. Garlena, Daniel A. Russell, Bailey E. Smith, Vaishnavi Mahalingam, Lawrence Abad, Christian H. Gauthier, Graham F. Hatfull
Publikováno v:
mBio, Vol 12, Iss 2 (2021)
Mycobacterium abscessusM. abscessusin vivo
Externí odkaz:
https://doaj.org/article/eb72c3f4f8a641e3b65ba6bbf8660b97
Autor:
Daniel A. Russell, Graham F. Hatfull, Ashley M. Divens, Christian Gauthier, Lawrence Abad, Vaishnavi Mahalingam, Haley G. Aull, Deborah Jacobs-Sera, Kira M. Zack, Rebecca A. Garlena, Carlos A Guerrero-Bustamante, Rebekah M. Dedrick, Bailey E. Smith
Publikováno v:
mBio
mBio, Vol 12, Iss 2 (2021)
mBio, Vol 12, Iss 2 (2021)
Mycobacterium abscessus infections in cystic fibrosis patients are challenging to treat due to widespread antibiotic resistance. The therapeutic use of lytic bacteriophages presents a new potential strategy, but the great variation among clinical M.
Autor:
Haley G. Aull, Deborah Jacobs-Sera, Vaishnavi Mahalingam, Christian Gauthier, Daniel A. Russell, Rebekah M. Dedrick, Lawrence Abad, Bailey E. Smith, Graham F. Hatfull, Rebecca A. Garlena
Publikováno v:
mBio
mBio, Vol 12, Iss 2 (2021)
mBio, Vol 12, Iss 2 (2021)
Mycobacterium abscessus is an important emerging pathogen that is challenging to treat with current antibiotic regimens. There is substantial genomic variation in M. abscessus clinical isolates, but little is known about how this influences pathogeni